Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial have?
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial has 816 citations in the OpenAlex counts ScholarIQ stores.
When was Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial published?
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial has 2022 year in the ScholarIQ index.
What is the open-access status of Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial?
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial?
The DOI for Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial is on the source record.
What is the PMID of Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial?
The PMID for Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial is on the source record.
What is the OpenAlex record for Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial?
The OpenAlex for Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial is on the source record.